US Judge Rejects Novo Nordisk Bid to Block Lilly Ads
A US judge denied Novo Nordisk requests to block Eli Lilly advertising for weight loss drugs. The court found no proof of irreparable harm to sales or reputation.
Xurve View
Insights:
Xurve View
A United States federal judge rejected NOVO NORDISK A/S-B's request to block ELI LILLY & CO from running weight-loss drug advertisements. The decision preserves marketing campaigns in a pharmaceutical sector generating tens of billions of dollars in annual sales.
